1Liumbruno G, Bennardello F, Lattanzio A, et al. Recommendations for the transfusion of plasma and platelets. Blood Transfus,2009,7 (2) :132-150.
2Duguid J, O'Shaughnessy DF, Atterbury C, et al. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupematant. Br J Haemato1,2004 ,126 ( 1 ) : 11-28.
3British Committee for Standards in Haematology. Guidelines for the use of platelet transfusions. Br J Haemato1,2003,122 ( 1 ) :10-23.
4Salem DN, Stein PD ,Al-Ahmad A, et al. Antithrombotic therapy in valvular heart disease-native and prosthetic: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest, 2004,126(3 Suppl) :457S-482S.
5Stainsby D, MaeLennan S,Thomas D, et al. Guidelines on the man- agement of massive blood loss. Br J Haemato1,2006 ,135 ( 5 ) : 634 - 641.
6Hiippala, ST. Replacement of massive blood loss. Vox Sanguinis, 1998,74 ( Suppl. 2) ,399-407.
7Reiss RF. Hemostatic defects in massive transfusion : rapid diagnosis and management. Am J Crit Care,2000,9(3) :158-165.
8Stanworth, SJ, Brunskilt, SJ, Hyde, CJ. , et al. Is fresh frozen plasma clinically effective? A systematic review of randomised controlled trials. Br J Haematol,2004,126 ( 1 ) : 139-152.
9United Kingdom Haemophilia Centre Directors'Organization. Guidelines on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders. Haemophilia, 2003,9(1 ) :1-23.
10Evans G, Llewelyn C, Luddington R, et al. Solvent/detergent fresh frozen plasma as primary treatment of acute thrombotic thrombocytopenic purpura. Clin Lab Haematol, 1999,21 ( 2 ) : 119-123.
10OShaughnessy DF,Atterbury C,Bolton Maggs P,et al.Guide-linesfor the use of fresh-frozell plasma,cryoprecipitate an d cry-osupema-tant[J].Br J Haematol ,2004,126(1):11-28.
